Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 13;2(4):zcaa029. doi: 10.1093/narcan/zcaa029

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020. Published by Oxford University Press on behalf of NAR Cancer.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 6. — DLBCL OS and PFS according to AID expression and BG4 staining. (A) Kaplan–Meier curves of OS (top) and PFS (bottom) of DLBCL patients who received RCHOP treatment according to low or high AID mRNA, AID protein or BG4 staining. Cut points were determined using the Youden index derived from ROC curves: AID mRNA, OS > 9.95 and PFS > 10.94 log₂ transformed; AID protein, OS > 5% and PFS > 30% positive staining cells; BG4 staining, OS > 61% and PFS > 0%. (B) Plot of the Cox proportional hazards model for 17 matched cases with data for all three variables where mean expression of the covariates is used in relation to survival probability. Corresponding coefficients are shown in the table. P-values were obtained from the log-rank test and the Cox proportional hazards multivariate analysis where DLBCL COO was a covariate.